EcoDrugPlus

Acetylcholinesterase

Ensembl ID : ENSAPEG00000011022
Gene Symbol: ACHE
1 Cross references
232 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSAPEG00000023363
Gene Symbol: ACVR2B
1 Cross references
196 Possible Orthologues:

Activin A Receptor Type 2ba

Ensembl ID : ENSAPEG00000001496
Gene Symbol: ACVR2BA
1 Cross references
194 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSAPEG00000006116
Gene Symbol: ADORA1
1 Cross references
208 Possible Orthologues:

Adenosine A1 Receptor B

Ensembl ID : ENSAPEG00000019884
Gene Symbol: ADORA1B
1 Cross references
201 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSAPEG00000006232
Gene Symbol: ADORA2A
1 Cross references
200 Possible Orthologues:

Adenosine A2a Receptor A

Ensembl ID : ENSAPEG00000002062
Gene Symbol: ADORA2AA
1 Cross references
188 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSAPEG00000016100
Gene Symbol: ADORA2B
1 Cross references
199 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSAPEG00000005052
Gene Symbol: ADORA3
1 Cross references
128 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSAPEG00000001954
Gene Symbol: ADA
1 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSAPEG00000012750
Gene Symbol: ADRA1AA
1 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSAPEG00000004663
Gene Symbol: ADRA1B
1 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).